explore -WSS

explore

author：comprehensive 2025-09-28 00:48:45 - browse：8

Primary care exam 01 — ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and Medtronic have run studies that showed renal denervation leads to a modest decrease in blood pressure. Adam Berry/Getty Images

The Food and Drug Administration approved a surgical system used to reduce blood pressure from Recor Medical, the company announced Wednesday. The treatment, called renal denervation, is controversial in the cardiology community due to its unclear efficacy.

Renal denervation is a treatment for patients who cannot manage standard doses of blood pressure medication — whether because the drugs aren’t effective enough for them, create overwhelming side effects, or become too cumbersome. The therapy, which is meant to be a one-time procedure, is administered via a catheter. Electrodes on the catheter then emit radiofrequency or ultrasound energy to block nerve signals from the kidneys that increase blood pressure.

The therapy, a simple procedure to reduce the blood pressure of millions of Americans, was once seen as a boon for cardiologists and device makers. But a large-scale clinical trial from Medtronic in 2014 called renal denervation’s efficacy into question, as it did not significantly reduce blood pressure compared to placebo treatments.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： CVS Caremark has created a new ploy: the drug ‘rebate credit’

entertainment

WSS

AstraZeneca to buy developer of next

Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

Gene editing the human germline: What are the risks?

New requirements coming in 2024 for Americans traveling to Europe

Severe heat forecast: Where scorching temperatures will persist over the next week

App could help diagnose ear infections more accurately — and at home

leisure time

explore

entertainment

Jerome Adams on the need for new antivirals for Covid

UnitedHealth increases loan offers after Change Healthcare outage

United colonoscopy coverage change 'may cost lives,' doctors say

Virtual Event: March of the Biosimilars

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How a key Senate committee is planning to regulate PBMs

Cancer drug shortages should be causing more outrage

Positive childhood experiences can help future health

What does generative AI mean for health care? We asked experts

Readout Newsletter: Bluebird, CVS, Contineum

focus

Virtual Event: March of the Biosimilars

FDA approves first blood sugar monitor without finger pricks

Creating egg and sperm cells from stem cells raises ethical issues

Men with early prostate cancer can safely opt out of treatment

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

FDA approves first blood sugar monitor without finger pricks

leisure time

Wikipedia

entertainment

focus